Medtronic Raises Outlook on Heart Device Demand
Medtronic has once again revised its financial outlook upward, driven by increasing demand for its heart devices. With this move, the company has sent a strong signal to investors.
The upward revision of the company's outlook is underpinned by steadily rising demand for heart devices. This indicates that growth continues in one of Medtronic's main business segments.
This decision by Medtronic reflects the improvement in the company's operational performance and the positive trend in market demand. The repeated upward revision further strengthens the company's near-term expectations.
Investors are closely monitoring this positive development in Medtronic's heart device segment. The company's future financial results will depend on whether this demand continues.
Not investment advice.
📊 MDT — Piyasa Yorumu
▲ up · 55%Medtronic's upgraded outlook on heart device demand could be a positive catalyst for the stock in the short term. However, technical indicators are giving mixed signals: RSI at 41 is in neutral-weak territory, MACD is below the signal line, and the price is slightly below the 20-day moving average. Although the 1.5% increase in the last 24 hours supports momentum along with the news, holding above the 50-day average is critical. The impact of the news may be limited; there is potential for a 1-3 day rise, but a strong trend reversal requires volume and additional buying signals.
RSI 14
41.3
MACD
0.03
24h Δ
1.52%
Canlı Grafikler
🔗 İlgili haberler
⭐ 67 · 06.08
BillionToOne Hisseleri %36 Düşerek Medikal Teknoloji Sektöründe Satış Dalgasına Yol Açtı
⭐ 67 · 08.06
Medtronic, SPR Therapeutics'i Satın Alarak Ağrı Müdahale Portföyünü Güçlendiriyor
⭐ 67 · 26.05
Medtronic, SPR Therapeutics'i Satın Almayı Planlıyor
⭐ 63 · 08.05
Jim Cramer, Rekabetin Intuitive Surgical'i Zayıflatabileceğini Düşünüyor
⭐ 68 · 06.05
Ottobock’un 1Ç 2026 geliri beklentileri aştı
⭐ 63 · 16.04
Mizuho Medtronic Hisse Hedefini Düşürdü, Olumlu Görüşünü Koruyor
🧬 Buna benzer
⭐ 67
Medtronic, SPR Therapeutics'i Satın Almayı Planlıyor
⭐ 67
Medtronic, SPR Therapeutics'i Satın Alarak Ağrı Müdahale Portföyünü Güçlendiriyor
⭐ 85
Blackstone ve TPG, Hologic'in cerrahi birimi için 4 milyar doların üzerinde talep ediyor
⭐ 67
Boehringer, Click’e 50 Milyon Dolarlık Dijital Terapötik Hakkı Devretti
AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.